| Catalog Number |
155402106 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Abscess (1690); Cellulitis (1768); Bone Fracture(s) (1870); Unspecified Infection (1930); Pain (1994); Seroma (2069); Limited Mobility Of The Implanted Joint (2671); No Code Available (3191)
|
| Date of Event |
12/18/2008
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
(b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
Patient was revised to address infection (right side).Doi: (b)(6) 2008 - dor: (b)(6) 2008.Update ad 11 apr 2019: (b)(4) has been re-opened under (b)(4) due to pinnacle claim submission form and medical records received.After review of medical records the patient was revised due to infection of right tha, decrease mobility, pain, hip abscess, hip popping and cellulitis.Operative note reported a lesion were debrided, infection is in the hip joint proper and had a cracked proximal femur.Added manufacturing date, expiration date, patient demographics, medical history and patient harm.Corrected patient identifier.Doi: (b)(6) 2008; dor: (b)(6) 2008; right hip.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary = > no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|